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Intrahepatic cholestasis of  pregnancy (ICP) is a rare 
disorder. It has most frequently been reported from 
Chili, Scandanavia and, less frequently, the United 
States (1-3). It has not pref iously been reported in 
black women (4)i The incidence is reported to be 
from 1 in 750 to I in 8000 gestations (2, 5). The 
disorder is felt to be entirely benign to the mother 
and is not associated with residual liver damage. It 
is characterized by pruritis with mild bilirubin ele- 
vatior~ and mild transaminasemia. Both pruritik' and 
jaundice . disappear rapidly after delivery. Differen, 
tiation of  this entity from other disorders that may 
cause jaundice during pregnancy is important. Viral 
hepatitis is .the most common cause in this country 
(6, 7). Prenatal diagnosis of  hepatitis B is particu- 
larly important, since treatment of infants at birth 
can prevent neonatal hepatitis (8). The differentia- 
tion of  virN hepatitis from ICP is usually not  
difficult. However, some cases of  ICP have been 
reported in which transaminases are markedly eleL 
rated, causing confusion with actute Viral hepatitis 
(9), We report here a case of [ntrabepatic choles{a- 
sis of pregnancy in a black woman that was associ- 
ated with marked elevation of transaminases and 
moderate signs of cholestasis. 
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CASE REPORT 
The patient was a 36-year-old black health-care profes- 
sional gravida 4 para 3 who presented with severe pruritis 
and mild nausea of approximately 1 week duration. The 
patient was at 38 weeks gestation, and her pregnancy had 
been without complications. She had severe generalized 
pmritis including the palms and soles. Pna-itis was par- 
ticularty prominent at night. She had noted mild nausea 
(without emesis or anorexia), darkening of urine, and 
lightening of stool, She had no abdominal p~iin, fever, 
malaise, skin rash, arthralgias, or adenopathy. She had a 
past medical history of hypertension with her first tall- 
term l~regnancy, but without significant proteinuria or 
other signs of toxemia. Neither wevious oral contracep- 
tive therapy nor previous pregnancies were associated 
with pruritis or jaundice. She had no history of liver 
disease, needle stick, or blood transfusion, and had had 
previous negative hepatitis B serologies. She had no 
family history of liver disease, pruritis, or jaundice asso- 
dated v, ith pregnancies. Her medications included pre- 
natal vitamins and iron. 
Physical examination w.as remarkable for a normal 
fundoscopic examination, and the absence of scleral 
ieterus, spider arigiomata, or other stigmata of chronic 
liver disease. She had trace pedal edema. Neurological 
examinati'on was normal. The uterus was consistent with 
gestational date and good fetal heart tones were noted. 
Routine !aboratory stBdies showed a normal hematocrit 
of 40% with a white blood eel] count of 7300 and normal 
platel.et count. Bilimbin, transaminases, and alkaline 
phosphatase were elevated as indicated in Table 1. 
Urinalysis revealed trace bilirubin, but no protein, glu- 
cose, or ketones. Protkrombin time and portia! thrombo- 
plastin time were normal. Hepatitis B surface antigen, 
surface antibody, and core antibody were negative. Hep- 
atitis A antibody (tgM) was negative. Serology for CMV, 
toxoplasmosis, herpes, and rubella were uriremarkable, 
The patient's course was characterized by continued 
prurltis and increasing bilirubin without other symptoms. 
Blood wessure was noted to be elevated a~ 120./85 one 
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TABLE 1. L_~,SORATORY DAIA 
Date 
715 7 / 7  7/9 7/11" 7/12 7/14 7/16 7/27 9/28 
GOT (AST) (2-35 268 
iU/liter) 
GPT (ALT) (2-35 60(1 
IUfliter) 
Alkaline phosphatase 283 
(30--96 lU/liter) 
GGTP (1-35 IU?liter) 
Bilirabin (0.1-0.9 rngEdi) 
Cholylglyclne (0--40 9,g/dl) 
0.7 
332 249 297 207 97 62 33 18 
715 615 610 497 338 241 43 27 
291 294 289 238 220 204 130 96 
40 38 40 32 28 
1.1 1.3 0.7 0.6 0.7 0.7 0.6 
9O0 29.7 
*Delivered on July 11. 
WILSON 
day prior to induction, Urine remained free of protein. 
Delivery was induced by pitocin without complications. 
The 3750-gram female infant was healthy with an Apgar 
of 9 at 5 rain. The patient had a rapid decrease in pruritis 
with resolutionby day 4 postpartum. Enzymes dropped 
rapidly as indicated in Table 1. Her postpartum course 
was complicated by endometrifis which responded well to 
antibiotic therapy. During 6-month follow-up, she has had 
no further symptoms, gallbladder ultrasound was normal, 
and her enzymes have returned to normal. Antimitochon- 
drial antibody was negative. 
DISCUSSION 
This case illustrates many of the classic features 
of intrahepatic cholestasis of pregnancy. The pa- 
tient had the onset of her symptoms late in preg- 
nancy. This pattern has been observed in most of 
the reported cases (1, 2, 4, 5, 7), although some 
patients have had symptoms as early as the sixth 
week of gestation (7). Prurifis is the predominant 
symptom in most patients, as was the case in this 
patient. Jaundice may not occur. However, when it 
does, it follows the onset of pruritis by one to two 
weeks extending up to 22 weeks (2, 7). Our patient 
had a slow rise in her bilirubin without icterus. 
Darkening of urine and lightening of stool are seen 
in some of the patients and usually precedes clinical 
jaundice (7). The paucity of other symptoms and 
signs are a hallmark of this disorder, in particular 
the absence of biliary colic, fever, and general 
malaise (4, 7). The rapid resolution of symptoms 
with delivery is expected. In almost all cases, 
pruritis resolves by two weeks postpartum, with 
most clearing in the first week. 
In most cases, the biocheaiic~ features present 
are those of chotestasis. Alkaline phosphatase is 
usually elevated but may fall in the range of that 
seen in normal pregnancy (7). Our patient had 
moderate elevation of alkaline phosphatase. This 
enzyme has been reported to fall slowly after deliv- 
ery and, as in this case, may be the last to return 
to normal (2, 7). Gammagtutamyltranspepttdase 
(GGTP) was elevated in this case. This enzyme is 
particularly useful during pregnancy, since it is 
elevated with cholestasis and is not affected by 
pregnancy (10). Serum bile acids are very sensitive 
indicators of cholestasis. Serum bile acids, espe- 
cially chotic acid, are significantly greater in ICP 
than in normal pregnancy (11) and correlate with 
pruritis better than bilirubin and alkaline phospha- 
tase (9). The patient had cholic acid elevated >20- 
fold, which rapidly returned to normal after deliv- 
e ly .  
One of the unusual aspects of this ease is the 
oecun'ence of ICP in a black American, which has 
not been reported previously (4). ICP has been 
reported in Europe, North and South America, and 
Australia, however the disorder is rare, with inci- 
dence estimated at from I in every 750-8000 gesta- 
tions (1-3). Much higher incidences are reported in 
the Sc~mdinavian countries, Poland, and Chile, the 
latter having the highest rates (one case in every ten 
gestations) in some areas of the country (I2). Stud- 
ies in Chile (13) and in other countries (14, 15) 
suggest genetic factors with inheritance in a sex- 
limited, Mendelian dominant pattern. No linkage 
with HLA histocompatibility antigens has been 
demonstrated. The disorder is associated with sen- 
sitivity to ethinyl estradiol, resembling symptoms 
encountered with pregnancy (16, 17). This response 
can serve as a possible screening study for demon- 
stration of the trait. 
The patient in this report had had no symptoms 
with two previous full-term pregnancies and oral 
contraceptive therapy. Multiparous women may 
display marked variation in the onset and severity 
in each gestation. Frequently patients will have one 
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or more asymptomatic pregnancies before ICP oc- 
curs. However, subsequent pregnancies will usu- 
ally be affected, although severity may vary (2). 
Marked elevation of transaminases was noted in 
this patient. The serum glulamic pyruvic transami- 
nase (SGPT, alanine aminotransferase) was ~20- 
fold elevated. This is in comparison with serum 
glutamic oxaloacetic transaminasc (SGOT, aspar- 
late aminotransferase), which was only eighffotd 
elevated. This pattern raises the question of viral 
hepatitis, particularly since (1) the patient was a 
health-care professional, (2) viral hepatitis is the 
most common cause of jaundice in pregnancy in this 
country, and (3) transaminases are usually less than 
200 in ICP (5, 7, 9). 
It is now important to diagnose viral hepatitis B 
because transmission to the child can be prevented 
by hepatitis B immune serum globulin and hepatitis 
B vaccination (8, 18, 19). Acute non-A, non-B 
hepatitis is a possibility in this case, and it cannot 
definitely be eliminated. Serological tests are not 
available, and liver histology was not performed. 
Perhaps the etfect of estrogenic hormones may haste 
induced a disproportionately cholestatic picture (7). 
The cholestatic state of the last trimester of preg- 
nancy is demonstrated by the increased bromosulph- 
thalein (BSP) retention due to a reduction of BSP 
secretion into bile (20). The course of viraI hepatitis 
in pregnancy is generally not different from that in 
nonpregnant women in the Western countries (6, 7, 
!6). In India, Africa, and the Middle East, the 
severity of acute viral hepatitis increases during 
pregnancy (6, 7, 21). A recent study from In6ia 
reported an increased incidence of non-A, non-B 
hepatitis during pregnancy with an increased inci- 
dence of fulminant hepatitis during the third trimes- 
ter (21). Malnutrition has been suggested as a cause 
for the severity of hepatitis in these countries (5-7). 
However, in this patient, viral hepatitis was un- 
likely in view of the lack of constitutional symp- 
toms, negative serologies [hepatitis B surface anti- 
gen and antibody, hepatitis B core antibody, and 
hepatitis A (lgM) antibody], markedly elevated se- 
rum bile acid, and very rapid decline in serum 
transaminases in the immediate postpartum period. 
Hepatic abnormalities have also been noted with 
toxemia of pregnancy (5, 22). Thcsc abnormalities 
are usually associated with disseminated intravas- 
eular coagulopathy which has been shown to result 
in venous thrombi, hemorrhage, fibrin deposition, 
and cell-necrosis (22, 23). The spectrum is quite 
variable. Although this patient had mild hyperten- 
sion, she had no evidence of eclampsia or preec- 
lampsia and had normal platelet count and coagula- 
tion parameters. 
Chronic liver disease, such as primary biliary 
cirrhosis (PBC), might be considered in this patient. 
PBC may appear during the last trimester of preg- 
nancy, where it presumably adds an additional 
cholestatic factor to that seen in normal pregnancy, 
as noted above (20, 24). The resultant cholestatic 
picture could mimic 1CP. However, pruritis associ- 
ated with PBC usually persists after delivery, al- 
though it may resolve and reappear later (24, 25). 
PBC is unlikely in this case since pruritis disap- 
peared, alkaline phosphatase returned to normal, 
and the antimitochondrial antibody was negative. 
The infant in this case suffered no untoward 
effects. Until recently, the clinical course of  ICP 
was generally expected to be benign for both 
mother and child. However, several reports suggest 
that ICP is associated with an increased incidence 
of premature delivery and stillbirths (9, 26, 29). 
Placental studies in ICP reveal some nonspecific 
changes that may contribute to fetal hypoxia and 
distress. Elevated maternal serum bile acids resull 
in elevation in fetal serum and may mediate fetal 
distress (28). 
This case illustrates several classic features of 
ICP, including onset and clinical course; however, 
it emphasizes some of the less common aspects--- 
occurrence in a black American, onset in a later 
pregnancy in a multiparous woman, and a biochem- 
ical pattern of markedly elcvated transaminases. 
SUMMARY 
A case of intrahepatic cholestasis of pregnancy 
(ICP) in a black American is presented. This is the 
first case reported in a black. Marked elevation of 
transaminases with mild biochemical evidence of 
cholestasis was initially suggestive of viral hepati- 
tis. A clinical course characterized by pruritis with 
mini real constitutional symptoms, rapid resolution 
of biochemical abnormalities after delivery, and 
negative hepatitis A and B serologies was consist- 
ent with the diagnosis of ICP. Review of the classic 
features of tCP with emphasis on some unusual 
aspects of the disorder is included. 
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